PDG108 CLINICAL OUTCOMES ON SWITCHING BETWEEN NEWER P2Y12 RECEPTOR INHIBITORS AND CLOPIDOGREL IN DUAL ANTIPLATELET THERAPY IN HONG KONG ACUTE CORONARY SYNDROME POPULATION USING REAL WORLD DATA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1121
https://www.valueinhealthjournal.com/article/S1098-3015(19)33499-0/fulltext
Title :
PDG108 CLINICAL OUTCOMES ON SWITCHING BETWEEN NEWER P2Y12 RECEPTOR INHIBITORS AND CLOPIDOGREL IN DUAL ANTIPLATELET THERAPY IN HONG KONG ACUTE CORONARY SYNDROME POPULATION USING REAL WORLD DATA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33499-0&doi=10.1016/j.jval.2019.09.1121
First page :
Section Title :
Open access? :
No
Section Order :
10977